epirubicin has been researched along with Fallopian Tube Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chao, HT; Juang, CM; Ng, HT; Wang, PH; Yuan, CC | 1 |
| Cosio, S; Fanucchi, A; Gabriele, A; Gadducci, A; Landoni, F; Maggino, T; Rossi, R; Sartori, E; Tisi, G; Zola, P | 1 |
| Halligan, AW; McGuinness, EP | 1 |
3 other study(ies) available for epirubicin and Fallopian Tube Neoplasms
| Article | Year |
|---|---|
Prognosis of primary fallopian tube adenocarcinoma: report of 25 patients.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Epirubicin; Fallopian Tube Neoplasms; Fallopian Tubes; Female; Follow-Up Studies; Humans; Neoplasm Staging; Prognosis; Radiotherapy, Adjuvant; Registries; Retrospective Studies; Risk Factors | 1998 |
Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Epirubicin; Fallopian Tube Neoplasms; Female; Humans; Hysterectomy; Middle Aged; Neoplasm Staging; Ovariectomy; Reoperation; Retrospective Studies; Salpingostomy; Survival Rate; Treatment Failure | 2001 |
Malignant fibrous histiocytoma of the fallopian tube.
Topics: Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Fallopian Tube Neoplasms; Female; Histiocytoma, Benign Fibrous; Humans; Ifosfamide; Mesna; Middle Aged; Neoplasm Recurrence, Local | 1990 |